Chentoufi A, Ulmer J, BenMohamed L
Vaccines (Basel). 2025; 13(1).
PMID: 39852809
PMC: 11769099.
DOI: 10.3390/vaccines13010030.
Diaz-Dinamarca D, Cardenas-Caceres S, Muena N, Diaz P, Barra G, Puentes R
Vaccines (Basel). 2024; 12(8).
PMID: 39204043
PMC: 11359105.
DOI: 10.3390/vaccines12080919.
Kesika P, Thangaleela S, Sisubalan N, Radha A, Sivamaruthi B, Chaiyasut C
Pathogens. 2024; 13(2).
PMID: 38392902
PMC: 10892479.
DOI: 10.3390/pathogens13020164.
Szardenings M, Delaroque N, Kern K, Ramirez-Caballero L, Puder M, Ehrentreich-Forster E
Vaccines (Basel). 2023; 11(9).
PMID: 37766081
PMC: 10535424.
DOI: 10.3390/vaccines11091403.
Li L, Zhao Z, Yang X, Su Z, Li W, Chen S
Adv Sci (Weinh). 2023; 10(20):e2207474.
PMID: 37162232
PMC: 10369230.
DOI: 10.1002/advs.202207474.
Early transcriptional and epigenetic divergence of CD8+ T cells responding to acute versus chronic infection.
Quezada L, Jin W, Liu Y, Kim E, He Z, Indralingam C
PLoS Biol. 2023; 21(1):e3001983.
PMID: 36716323
PMC: 9886247.
DOI: 10.1371/journal.pbio.3001983.
Molecular markers for early stratification of disease severity and progression in COVID-19.
Kashyap A, Sebastian S, Krishnaiyer NarayanaSwamy S, Raksha K, Krishnamurthy H, Krishna B
Biol Methods Protoc. 2022; 7(1):bpac028.
PMID: 36518355
PMC: 9731223.
DOI: 10.1093/biomethods/bpac028.
Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV.
Shekhawat U, Roy Chowdhury Chakravarty A
J Biol Phys. 2022; 48(4):399-414.
PMID: 36422744
PMC: 9686260.
DOI: 10.1007/s10867-022-09615-x.
Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients.
Wang L, Zhao J, Schank M, Khanal S, Dang X, Cao D
Mol Immunol. 2022; 152:215-223.
PMID: 36379129
PMC: 9630139.
DOI: 10.1016/j.molimm.2022.10.016.
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
Barbier M, Lee K, Vikharankar M, Rajpathak S, Kadam N, Wong T
Front Immunol. 2022; 13:948431.
PMID: 36091051
PMC: 9450042.
DOI: 10.3389/fimmu.2022.948431.
B.1.1.7 (Alpha) variant is the most antigenic compared to Wuhan strain, B.1.351, B.1.1.28/triple mutant and B.1.429 variants.
Bhattacharya M, Sharma A, Mallick B, Lee S, Seo E, Chakraborty C
Front Microbiol. 2022; 13:895695.
PMID: 36033846
PMC: 9411949.
DOI: 10.3389/fmicb.2022.895695.
Auxiliary Screening COVID-19 by Serology.
Pan X, Kaminga A, Chen Y, Liu H, Wen S, Fang Y
Front Public Health. 2022; 10:819841.
PMID: 35983367
PMC: 9380738.
DOI: 10.3389/fpubh.2022.819841.
Two Years into the COVID-19 Pandemic: Lessons Learned.
da Silva S, do Nascimento J, Mendes R, Guarines K, Targino Alves da Silva C, Silva P
ACS Infect Dis. 2022; 8(9):1758-1814.
PMID: 35940589
PMC: 9380879.
DOI: 10.1021/acsinfecdis.2c00204.
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients.
Garanina E, Hamza S, Stott-Marshall R, Martynova E, Markelova M, Davidyuk Y
Front Microbiol. 2022; 13:842232.
PMID: 35509311
PMC: 9058163.
DOI: 10.3389/fmicb.2022.842232.
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2.
Obaidullah A, Alanazi M, Alsaif N, Albassam H, Almehizia A, Alqahtani A
RSC Adv. 2022; 11(29):18103-18121.
PMID: 35480208
PMC: 9033181.
DOI: 10.1039/d1ra02885e.
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies.
Guo D, Duan H, Cheng Y, Wang Y, Hu J, Shi H
Mol Biomed. 2022; 3(1):12.
PMID: 35461370
PMC: 9034971.
DOI: 10.1186/s43556-022-00074-3.
Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan.
Furukawa H, Oka S, Higuchi T, Yamaguchi M, Uchiyama S, Koiwa T
Clin Med Insights Circ Respir Pulm Med. 2022; 16:11795484221075492.
PMID: 35401020
PMC: 8990541.
DOI: 10.1177/11795484221075492.
Molecular recognition of SARS-CoV-2 spike glycoprotein: quantum chemical hot spot and epitope analyses.
Watanabe C, Okiyama Y, Tanaka S, Fukuzawa K, Honma T
Chem Sci. 2022; 12(13):4722-4739.
PMID: 35355624
PMC: 8892577.
DOI: 10.1039/d0sc06528e.
Peptides for Vaccine Development.
Hamley I
ACS Appl Bio Mater. 2022; 5(3):905-944.
PMID: 35195008
PMC: 9384901.
DOI: 10.1021/acsabm.1c01238.
Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.
Mukherjee P, Efferth T, Das B, Kar A, Ghosh S, Singha S
Phytomedicine. 2022; 98:153930.
PMID: 35114450
PMC: 8730822.
DOI: 10.1016/j.phymed.2022.153930.
